A new report warns that SA’s rollout of the six-monthly HIV-prevention jab, lenacapavir, could falter after US funding cuts gutted outreach networks. Findings draw on interviews with healthcare workers and high-risk groups in Cape Town and Johannesburg.
Related Posts
Coming Soon: An EU Plan To Combat Youth Poverty
In early March, the EU’s youngest Commissioner is to unveil his plan to get Europe’s Gen-Z generation a fairer deal. Glenn Micaleff, Malta’s 36-year-old […]
Impeachment Inquiry: President Ramaphosa To Address Nation Tonight
Pretoria – The Presidency has announced that President Cyril Ramaphosa will address the nation tonight at 20:00 regarding the judgment of the Constitutional Court […]
News24 | Sam Sole | Mozambican group RGS ups the stakes in Tongaat court battle
The stakes are enormous amid legal battles over the rescue and future of SA’s biggest sugar producer Tongaat, writes amaBhungane’s Sam Sole.